Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 27, Issue 4, 2014, Pages 303-316

  Bianchi, Andrea ^a   Dufort, Sandrine ^b,c,f   Lux, François ^d   Courtois, Arnaud ^e   Tillement, Olivier ^d   Coll, Jean Luc ^b,f   Crémillieux, Yannick ^a  

^a CNRS University Bordeaux Segalen   (France)

^b UNIV GRENOBLE ALPES   (France)

^c Nano H ^*  (France)

^d UNIVERSITÉ LYON 1   (France)

^e CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^f INSERM   (France)

Author keywords

Fluorescence imaging; Gadolinium based nanoparticles; Lung; Multimodal nanoparticles; Pharmacokinetics; UTE MRI

Indexed keywords

ANIMALIA; MUS;

EID: 84905095699     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-013-0412-5     Document Type: Article

References (43)

1. Beckmann N, Cannet C, Karmouty-Quintana H, Tigani B, Zurbruegg S, Blé F-X, Crémillieux Y, Trifilieff A (2007) Lung MRI for experimental drug research. Eur J Rad 64:381-396
2. Wielpütz M, Kauczor H-U (2012) MRI of the lung: state of the art. Diagn Interv Radiol 18:344-353
3. Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, Van Beek EJR (2012) MRI of the lung (2/3). Why...when...how? Insights. Imaging 3(4):355-371
4. Mosbah K, Ruiz-Cabello J, Berthezène Y, Crémillieux Y (2008) Aerosols and gaseous contrast agents for magnetic resonance imaging of the lung. Contrast Media Mol Imaging 3:173-190
5. Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, Molinari F, Van Beek EJR, Biederer J (2012) MRI of the lung (1/3): methods. Insights Imaging 3(4):345-353
6. Bergin CJ, Pauly JM, Macovski A (1991) Lung parenchyma: projection reconstruction MR imaging. Radiology 179:777-781
7. Bergin CJ, Noll DC, Pauly JM, Glover GH, Macovski A (1992) MRI imaging of lung parenchyma: a solution to susceptibility. Radiology 183:673-676
8. Zurek M, Bessaad A, Cieslar K, Crémillieux Y (2010) Validation of simple and robust protocols for high-resolution lung proton MRI in mice. Magn Reson Med 64:401-407
9. Gobbo OL, Zurek M, Tewes F, Ehrhardt C, Crémillieux Y (2012) Manganese: a new contrast agent for lung imaging? Contrast Media Mol Imaging 7:542-546
10. Beckmann N, Kneuer R, Gremlich H-U, Karmouty-Quintana H, Blé F-X, Müller M (2007) In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed 20:154-185
11. Roller J, Laschke MW, Tschernig T, Schramm R, Veith NT, Thorlacius H, Menger MD (2011) How to Detect a Dwarf. In Vivo Imaging of Nanoparticles in the Lung. Nanomed Nanotechnol Biol Med 7:753-762
12. Bianchi A, Lux F, Tillement O, Crémillieux Y (2012) Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles. Magn Reson Med. doi: 10.1002/mrm.24580
13. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB (2000) Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 55:24-35
14. Costa DL, Lehmann JR, Winsett D, Richards J, Ledbetter AD, Dreher KL (2006) Comparative pulmonary toxicological assessment of oil combustion particles following inhalation or instillation exposure. Toxicol Sci 91:237-246
15. Shoyele SA, Cawthome S (2006) Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev 58:1009-1029
16. Berthezène Y, Vexler V, Clément O, Mühler A, Moseley ME, Brasch RC (1992) Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. Radiology 183:667-672
17. Haage P, Karaagac S, Adam G, Glowinski A, Günther RW (2001) Comparison of aerosolized gadoteridol and gadopentetatedimeglumine for magnetic resonance ventilation imaging of the lung. Magn Reson Med 46:803-806
18. Lux F, Mignot A, Mowat P, Louis C, Dufort S, Bernhard C, Denat F, Boschetti F, Brunet C, Antoine R, Dugourd P, Laurent S, Elst LV, Muller R, Sancey L, Josserand V, Coll J-L, Stupar V, Barbier E, Rémy C, Broisat A, Ghezzi C, Le Duc G, Roux S, Perriat P, Tillement O (2011) Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem 123:12507-12511
19. Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, Boschetti F, Bocher L, Gloter A, Stephan O, Antoine R, Dugourd P, Luneau D, Novitchi G, Figueiredo LC, De Morais PC, Bonneviot L, Albela B, Ribot F, Van Lokeren L, Dechamps-Olivier I, Chuburu F, Lemercier G, Villiers C, Marche PN, Le Duc G, Roux S, Tillement O, Perriat P (2013) A top-down synthesis route to ultrasmall multifunctional Gd-based nanoparticles for theranostic applications. Chem Eur J 19:6122-6136
20. Jackson JI, Meyer CH, Nishimura DG, Macovski A (1991) Selection of a convolution function for Fourier inversion using gridding. IEEE Trans Med Imaging 10:473-478
21. Armitage P, Behrenbruch C, Brady M, Moore N (2005) Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. Med Image Anal 9:315-329
22. Crémillieux Y, Briguet A, Deguin A (1994) Projection- reconstruction methods: fast imaging sequences and data processing. Magn Reson Med 32:23-32
23. Girard OM, Du J, Agemy L, Sugahara KN, Kotamraju VR, Ruoslahti E, Bydder GM, Mattrey F (2011) Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: comparison of T1, T2, and synergistic T1-T2 contrast mechanisms. Magn Reson Med 65:1649-1660
24. Strobel K, Hoerr V, Schmid F, Wachsmuth L, Löffler B, Faber C (2012) Early detection of lung inflammation: exploiting T1-effects of iron oxide particles using UTE MRI. Magn Reson Med 68:1924-1931
25. Laurent S, Elst LV, Muller RN (2006) Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 1:128-137
26. Zurek M, Alamidi D, Johansson E, Risse F, Olsson LE (2012) Accurate T1 mapping in rodent lungs using ultrashort echo-time MRI. In: proceedings of the 20th scientific meeting. International Society of Magnetic Resonance in Medicine, Melbourne, p 3975
27. Dhillon S, Kostrzewksi A (2006) Clinical Pharmacokinetics. Pharmaceutical Press, London
28. Brenner G, Stevens C (2012) Pharmacology. Saunders Elsevier, Philadelphia
29. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31
30. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A (2010) Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotech 28:1300-1303
31. Wagner JG (1975) Do you need a pharmacokinetic model, and, if so, which one? J Pharmacokinet Biop 3(6):457-478
32. Bauer LA (2005) Clinical pharmacokinetics handbook. McGraw-Hill Medical, New York City
33. Mehvar R (2001) Principles of nonlinear pharmacokinetics. Am J Pharm Educ 65:178-184
34. Le Duc G, Miladi I, Alric C, Mowat P, Bräuer-Krisch E, Bouchet A, Khalil E, Billotey C, Janier M, Lux F, Epicier T, Perriat P, Roux S, Tillement O (2011) Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 5:9566-9574
35. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV (2007) Renal clearance of nanoparticles. Nat Biotech 25:1165-1170
36. Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV (2010) Design considerations for tumour-targeted nanoparticles. Nat Nano 5:42-47
37. Roa WH, Azarmi S, Al-Hallak MK, Finlay WH, Magliocco AM, Löbenberg R (2011) Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J Control Release 150:49-55
38. Tigani B, Schaeublin E, Sugar R, Jackson AD, Fozard JR, Beckmann N (2002) Pulmonary inflammation monitored noninvasively by MRI in freely breathing rats. Biochem Biophys Res Commun 292:216-221
39. Beckmann N, Tigani B, Sugar R, Jackson AD, Jones G, Mazzoni L, Fozard JR (2002) Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI. Am J Physiol: Lung C 283:L22-L30
40. Okamoto T, Gohil K, Finkelstein EI, Bove P, Akaike T, van der Vliet A (2004) Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol: Lung C 286(1):L198-L209
41. Duan Y, Learoyd J, Meliton AY, Leff AR, Zhu X (2012) Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res 13:4
42. Zhong F, Chen H, Han L, Jin Y, Wang W (2011) Curcumin attenuates lipopolysaccharide-induced renal inflammation. Biol Pharm Bull 34:226-232
43. Takahashi K, Mizukami H, Kamata K, Inaba W, Kato N, Hibi C, Yagihashi S (2012) Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat. PLoS ONE 7(1):e30134